Literature DB >> 4026063

Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease.

M N Dohn, R P Baughman.   

Abstract

Patients with and without interstitial lung disease (ILD) underwent bronchoalveolar lavage (BAL) with 4 boluses of 60 ml of normal saline. Fluid was withdrawn after each bolus, and the results after the first and second bolus were pooled and compared with the results after the third and fourth bolus. In the control group (n = 9), there was a significantly higher percentage of lymphocytes and neutrophils after the first half than after the second half (first half: lymphocytes, 8 +/- 1.9%, mean +/- SEM; neutrophils, 2 +/- 1.2%. Second half: lymphocytes, 5 +/- 1.2% (p less than 0.01); neutrophils, 0.3 +/- 0.12% (p less than 0.05). In the ILD group (n = 8), there was a rise in the number of lymphocytes from 15 +/- 4.9% to 20 +/- 3.9% (p less than 0.05) and the number of neutrophils from 8 +/- 4.8% to 10 +/- 5.6%. The ILD group had more cells aspirated after the second half than after the first half of the BAL, whereas the control group did not. Abnormalities in the cell population of the BAL fluid were more striking when the larger volume was used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026063     DOI: 10.1164/arrd.1985.132.2.390

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  9 in total

Review 1.  Pulmonary disposition of antimicrobial agents: methodological considerations.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

2.  Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis.

Authors:  R P Baughman; R Shipley; C E Eisentrout
Journal:  Lung       Date:  1987       Impact factor: 2.584

3.  Bronchoalveolar lavage cell pattern from healthy human lung.

Authors:  M Heron; J C Grutters; K M ten Dam-Molenkamp; D Hijdra; A van Heugten-Roeling; A M E Claessen; H J T Ruven; J M M van den Bosch; H van Velzen-Blad
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 4.  Bronchoalveolar lavage as a research tool.

Authors:  E H Walters; P V Gardiner
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

5.  Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion.

Authors:  S L Newman; C Bucher; J Rhodes; W E Bullock
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

6.  Repeatability of cellular constituents and cytokine concentration in fluid obtained by non-bronchoscopic bronchoalveolar lavage of infants receiving extracorporeal oxygenation.

Authors:  R J Mildner; N A Taub; J R Vyas; H M Killer; R K Firmin; D J Field; S Kotecha
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

7.  Semiquantitative technique for estimating Pneumocystis carinii burden in the lung.

Authors:  R P Baughman; S Strohofer; G Colangelo; P T Frame
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

8.  Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages.

Authors:  S L Newman; L Gootee; C Bucher; W E Bullock
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Quantitative culture of endotracheal aspirate and BAL fluid samples in the management of patients with ventilator-associated pneumonia: a randomized clinical trial.

Authors:  Ricardo de Amorim Corrêa; Carlos Michel Luna; José Carlos Fernandez Versiani dos Anjos; Eurípedes Alvarenga Barbosa; Cláudia Juliana de Rezende; Adriano Pereira Rezende; Fernando Henrique Pereira; Manoel Otávio da Costa Rocha
Journal:  J Bras Pneumol       Date:  2014 Nov-Dec       Impact factor: 2.624

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.